Top Articles - News and Society

Federal fraud is a growing epidemic, that the authorities are aware of, but unfortunately can do little to prevent, without

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

the aid of the public. It would appear that until recently these people, usually federal employees themselves, did not have

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

the inclination to blow the whistle on their colleagues, either in fear of the backlash that it might draw on themselves, a

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

nd also there was no financial incentive or recognition in doing so.

Since the revamping of federal legislation, which bega

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

back in the mid 1980’s and has been constantly upgraded since then, there are now huge rewards available for federal employ

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ees who are prepared to take action in exposing any form of fraud being perpetrated against the federal government.

Under t

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

he current federal law, a person who provides information suggesting that a private individual or a business has provided fa

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

se information to either obtain money from the federal government or to defraud money from the federal government, then the

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

whistleblower is entitled to file a claim and may be liable to receive a reward running between 15% and 30% of the monies re

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

covered by the federal government.

The legislation, under its title “The False Claims Act” is a unique federal law that all

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ws citizens with evidence of fraud against the federal government to sue, on behalf of the government. This means that virtu

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ally anyone who receives money from the federal government, pays money to the federal government, or helps someone else get

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

money from the federal government, theoretically can bend the rules and violate the False Claims Act.

In addition to any re

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

wards distributed, under the False Claims Act, any employee who is discharged, demoted, harassed or otherwise discriminated

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

gainst because of lawful acts of the employee in furtherance of an action under the Act is entitled to receive compensation

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

and protection.

Such relief may include reinstatement, double back pay, and compensation for any special damages including

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

litigation costs and attorneys fees.

Federal authorities have taken full benefits from the legislation and the increased co

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

peration they are receiving from their employees.

Since these laws began to come into effect way back in 1986 the federal g

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

overnment has recovered over $2 Billion stolen by fraud, and brought to light as a result of actions by whistleblowers. The

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

government, in return, have distributed to date around $340 million dollars to informants as a reward for their cooperation

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/187213/toparticles-Federal-Fraud--A-Growing-Epidemic-Or-A-Disease-Contained.html">Federal Fraud - A Growing Epidemic Or A Disease Contained?</a>

BB link (for phorums):
[url=http://www.toparticles.org.ua/article/187213/toparticles-Federal-Fraud--A-Growing-Epidemic-Or-A-Disease-Contained.html]Federal Fraud - A Growing Epidemic Or A Disease Contained?[/url]

Offshore outsourcing is a big hit amongst Telemarketing Services. Many companies outsource work which involves high content. If the work can be transmitted over net, then companies prefer outsourcing to save cost.

Harried individuals who have applied for a home loan from a bank and received an approval letter will find some answers here. People get a tad disappointed when this approval letter is not accompanied by a regular sanction of the same. The problem lies in equating the approval letter with an actual promise for disbursement, which it definitely is not. Read on to know more:

Article on strategies and Guru's like Russ Whitney and Robert Allen who have influenced America's Real Estate Landscape.

Tags

Links

Top Articles - Federal Fraud - A Growing Epidemic Or A Disease Contained?

Related Articles: